These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 29397949)

  • 1. A Lymphedema Surveillance Program for Breast Cancer Patients Reveals the Promise of Surgical Prevention.
    Hahamoff M; Gupta N; Munoz D; Lee BT; Clevenger P; Shaw C; Spiguel L; Singhal D
    J Surg Res; 2019 Dec; 244():604-611. PubMed ID: 29397949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-Year Breast Surgeon Experience in LYMPHA at Time of ALND for Treatment of Clinical T1-4N1-3M0 Breast Cancer.
    Herremans KM; Cribbin MP; Riner AN; Neal DW; Hollen TL; Clevenger P; Munoz D; Blewett S; Giap F; Okunieff PG; Mendenhall NP; Bradley JA; Mendenhall WM; Mailhot-Vega RB; Brooks E; Daily KC; Heldermon CD; Marshall JK; Hanna MW; Leyngold MM; Virk SS; Shaw CM; Spiguel LR
    Ann Surg Oncol; 2021 Oct; 28(10):5775-5787. PubMed ID: 34365563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study.
    Zou L; Liu FH; Shen PP; Hu Y; Liu XQ; Xu YY; Pen QL; Wang B; Zhu YQ; Tian Y
    Breast Cancer; 2018 May; 25(3):309-314. PubMed ID: 29397555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantifying the Impact of Axillary Surgery and Nodal Irradiation on Breast Cancer-Related Lymphedema and Local Tumor Control: Long-Term Results From a Prospective Screening Trial.
    Naoum GE; Roberts S; Brunelle CL; Shui AM; Salama L; Daniell K; Gillespie T; Bucci L; Smith BL; Ho AY; Taghian AG
    J Clin Oncol; 2020 Oct; 38(29):3430-3438. PubMed ID: 32730184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphedema Incidence After Axillary Lymph Node Dissection: Quantifying the Impact of Radiation and the Lymphatic Microsurgical Preventive Healing Approach.
    Johnson AR; Kimball S; Epstein S; Recht A; Lin SJ; Lee BT; James TA; Singhal D
    Ann Plast Surg; 2019 Apr; 82(4S Suppl 3):S234-S241. PubMed ID: 30855393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of Lymphedema.
    Feldman S; Bansil H; Ascherman J; Grant R; Borden B; Henderson P; Ojo A; Taback B; Chen M; Ananthakrishnan P; Vaz A; Balci F; Divgi CR; Leung D; Rohde C
    Ann Surg Oncol; 2015 Oct; 22(10):3296-301. PubMed ID: 26202566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the Impact of Immediate Lymphatic Reconstruction for the Surgical Prevention of Lymphedema.
    Johnson AR; Fleishman A; Granoff MD; Shillue K; Houlihan MJ; Sharma R; Kansal KJ; Teller P; James TA; Lee BT; Singhal D
    Plast Reconstr Surg; 2021 Mar; 147(3):373e-381e. PubMed ID: 33620920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic Microsurgical Preventive Healing Approach for the Primary Prevention of Lymphedema: A 4-Year Follow-Up.
    Levy AS; Murphy AI; Ishtihar S; Peysakhovich A; Taback B; Grant RT; Ascherman JA; Feldman S; Rohde CH
    Plast Reconstr Surg; 2023 Feb; 151(2):413-420. PubMed ID: 36696330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of axillary surgery and radiotherapeutic strategy on the risk of lymphedema and upper extremity dysfunction in early breast cancer patients.
    Zheng SY; Chen CY; Qi WX; Cai G; Xu C; Cai R; Qian XF; Shen KW; Cao L; Chen JY
    Breast; 2023 Apr; 68():142-148. PubMed ID: 36764019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of the Axilla in T1-2 Breast Cancer Patients with Macrometastatic Sentinel Node Involvement Who Underwent Breast-Conserving Therapy.
    Kuru B; Yuruker S; Sullu Y; Gursel B; Ozen N
    J Invest Surg; 2019 Jan; 32(1):48-54. PubMed ID: 28945489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for breast cancer-related lymphedema: correlation with docetaxel administration.
    Aoishi Y; Oura S; Nishiguchi H; Hirai Y; Miyasaka M; Kawaji M; Shima A; Nishimura Y
    Breast Cancer; 2020 Sep; 27(5):929-937. PubMed ID: 32270417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of combined risk factors on breast cancer-related lymphedema: a study using decision trees.
    Jinbo K; Fujita T; Kasahara R; Jinbo R; Kisara S; Onobe J; Kimijima I; Yasuda M; Yamamoto Y
    Breast Cancer; 2023 Jul; 30(4):685-688. PubMed ID: 36917351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Simplified Lymphatic Microsurgical Preventing Healing Approach (S-LYMPHA) for the Prevention of Breast Cancer-Related Clinical Lymphedema After Axillary Lymph Node Dissection.
    Ozmen T; Lazaro M; Zhou Y; Vinyard A; Avisar E
    Ann Surg; 2019 Dec; 270(6):1156-1160. PubMed ID: 29794843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis.
    Wijaya WA; Peng J; He Y; Chen J; Cen Y
    Breast; 2020 Oct; 53():189-200. PubMed ID: 32858404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate-delayed lymphatic reconstruction after axillary lymph nodes dissection for locally advanced breast cancer-related lymphedema prevention: Report of two cases.
    Brahma B; Yamamoto T; Agdelina C; Adella D; Putri RI; Hanifah W; Sundah VH; Perdana AB; Putra MRA; Taher A; Panigoro SS
    Microsurgery; 2024 Jan; 44(2):e31033. PubMed ID: 36896960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supermicrosurgery lymphaticovenous and lymphaticolymphatic anastomosis: Technical detail and short-term follow-up for immediate lymphatic reconstruction in breast cancer treatment-related lymphedema prevention.
    Brahma B; Yamamoto T; Panigoro SS; Haryono SJ; Yusuf PA; Priambodo PS; Harimurti K; Taher A
    J Vasc Surg Venous Lymphat Disord; 2024 Jul; 12(4):101863. PubMed ID: 38428499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the prevention of secondary lymphedema.
    Agarwal S; Garza RM; Chang DW
    Breast J; 2020 Apr; 26(4):721-724. PubMed ID: 31631442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of neoadjuvant chemotherapy on breast cancer-related lymphedema after axillary lymph node dissection: a retrospective cohort study.
    Jia M; Pan L; Yang H; Gao J; Guo F
    Breast Cancer Res Treat; 2024 Apr; 204(2):223-235. PubMed ID: 38097882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the prevention and treatment of breast cancer-related lymphedema.
    Donahue PMC; MacKenzie A; Filipovic A; Koelmeyer L
    Breast Cancer Res Treat; 2023 Jul; 200(1):1-14. PubMed ID: 37103598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The All but Forgotten Mascagni-Sappey Pathway: Learning from Immediate Lymphatic Reconstruction.
    Johnson AR; Bravo MG; James TA; Suami H; Lee BT; Singhal D
    J Reconstr Microsurg; 2020 Jan; 36(1):28-31. PubMed ID: 31398762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.